Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2001; 37:1827-1835
© 2001 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zahn, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zahn, R.

Primary angioplasty versus intravenous thrombolysis in acute myocardial infarction: can we define subgroups of patients benefiting most from primary angioplasty?

Results from the pooled data of the maximal individual therapy in acute myocardial infarction registry and the myocardial infarction registry1

Ralf Zahn, MD*, Rudolf Schiele, MD*, Steffen Schneider, PhD*, Anselm K. Gitt, MD*, Harm Wienbergen, MD*, Karlheinz Seidl, MD*, Thomas Voigtländer, MD{dagger}, Martin Gottwik, MD{ddagger}, Gunther Berg, MD§, Ernst Altmann, MD||, Werner Rosahl, MD, Jochen Senges, MD* for the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) and the Myocardial Infarction Registry (MIR) Study Groups

* Department of Cardiology, Herzzentrum Ludwigshafen, Ludwigshafen, Germany
{dagger} Johannes Gutenberg Universität, Mainz, Germany
{ddagger} Klinikum Nürnberg, Nürnberg, Germany
§ Universitätskliniken Homburg/Saar, Homburg, Germany
|| Klinikum Friedrichstadt, Dresden, Germany
Städtisches Klinikum, Dessau, Germany



View larger version (40K):

[in a new window]
 
Figure 1 Selection of patients from the MITRA and MIR trials.

 


View larger version (21K):

[in a new window]
 
Figure 2 Multivariate analysis of hospital mortality for primary angioplasty and thrombolysis performed in different subgroups of patients. Adjustment was made for age, gender, location of infarction, cardiogenic shock, previous myocardial infarction (MI), resuscitation, heart failure at hospital admission, pre-hospital delay and type of revascularization, as well as concomitant therapy with beta-blockers and angiotensin-converting enzyme inhibitors. ECG = electrocardiogram.

 


View larger version (16K):

[in a new window]
 
Figure 3 Relationship between overall mortality and absolute risk reduction of dying by treatment with primary angioplasty compared with thrombolysis in the subgroups analyzed.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement